AGP Executive Report
Last update: 11 hours agoAI in Trials: A Pistoia Alliance poll finds 50% of clinical trial professionals see trust and regulatory uncertainty as the biggest barriers to AI adoption, urging validated, auditable approaches. Drug Discovery Push: Multiple reports highlight pharma’s push to speed trials and cut costs with AI-driven platforms and automation, while one commentary warns AI can cost more than clinicians once compute, oversight, and liability are counted. Imaging Equity: A Vanderbilt-led study of nearly 5,800 Medicare beneficiaries finds Black and Hispanic groups are less likely to show Alzheimer’s pathology on amyloid PET, raising concerns about downstream diagnosis and treatment gaps. Cancer Care Funding: A widow donates $1M to install a permanent PET/CT scanner at Hancock Health, after demand rose ~60% and mobile imaging created bottlenecks. Public Health Tech: NIH funds a $1.7M project to improve deep-vessel ultrasound imaging using light and nanoparticles. Maternal Care Model: UAMS pilots a toolkit to integrate doulas into hospital maternity teams. Tobacco Warning: IIT Gandhinagar and University of Illinois find herbal cigarettes can emit harmful particles comparable to or worse than tobacco. Food Safety: UK FSA recalls a frozen dessert due to undeclared hazelnuts and soya for allergy risk.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
